SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-17-002876
Filing Date
2017-04-25
Accepted
2017-04-25 08:04:15
Documents
5
Period of Report
2017-05-30
Effectiveness Date
2017-04-25

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2231911zdef14a.htm DEF 14A 417624
2 G427526.JPG g427526.jpg GRAPHIC 11748
3 G5970.JPG g5970.jpg GRAPHIC 9084
4 G23492BII001.GIF g23492bii001.gif GRAPHIC 147193
5 G23492BII002.GIF g23492bii002.gif GRAPHIC 122121
  Complete submission text file 0001047469-17-002876.txt   818833
Mailing Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139 617-863-5524
INVIVO THERAPEUTICS HOLDINGS CORP. (Filer) CIK: 0001292519 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37350 | Film No.: 17779757
SIC: 3841 Surgical & Medical Instruments & Apparatus